A Proof-of-Concept Trial to EvaluAte the EfficaCy and Safety Of Cell Therapy TRX103 Administered Intravenously in Patients With Active, Non-infectious Intermediate, Posterior, and Pan-Uveitis - PEACOCX Study
Latest Information Update: 02 Mar 2026
At a glance
- Drugs TRX 103 (Primary)
- Indications Uveitis
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Acronyms PEACOCX
Most Recent Events
- 02 Mar 2026 New trial record